Information Provided By:
Fly News Breaks for December 21, 2015
HNT, CNC
Dec 21, 2015 | 09:11 EDT
Susquehanna analyst Chris Rigg continues to believe Centene (CNC) shares look significantly undervalued on a pro-forma basis considering its post Health Net (HNT) earnings and revenue guidance. The analyst sees the potential for additional merger related upside from revenue and cost synergies as the transaction allows Centene to leverage Health Net's Medicare Advantage platform. Rigg reiterated his Positive rating and $87 price target on Centene shares.
News For CNC;HNT From the Last 2 Days
CNC
Apr 15, 2024 | 10:37 EDT
Shares of health care facilities and managed care are in the spotlight on Monday after Florida announced late on Friday five winners of six-year Medicaid managed care contracts. Among the winners... To see the rest of the story go to thefly.com. See Story Here
CNC
Apr 15, 2024 | 06:15 EDT
Wells Fargo raised the firm's price target on Centene (CNC) to $93 from $89 and keeps an Overweight rating on the shares. The firm notes Florida intends to award Medicaid contracts to Centene, Elevance Health (ELV), Humana (HUM) and two provider-run plans. Clearly the most positive for Centene given recent disappointing RFP performance and likely most disappointing for Molina Healthcare (MOH) given expectation for share gains, Wells says.